REPIN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.666600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.844800E-01
Normal-vs-Stage2
1.730750E-01
Normal-vs-Stage3
4.146200E-02
Normal-vs-Stage4
1.679790E-01
Stage1-vs-Stage2
2.839600E-01
Stage1-vs-Stage3
1.387190E-01
Stage1-vs-Stage4
2.772400E-01
Stage2-vs-Stage3
1.469560E-01
Stage2-vs-Stage4
6.044400E-01
Stage3-vs-Stage4
3.742800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.939000E-01
Normal-vs-AfricanAmerican
3.048600E-01
Normal-vs-Asian
2.473000E-01
Caucasian-vs-AfricanAmerican
8.810800E-01
Caucasian-vs-Asian
7.758000E-01
AfricanAmerican-vs-Asian
9.383200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.615800E-01
Normal-vs-Female
2.866800E-01
Male-vs-Female
8.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.698800E-01
Normal-vs-Age(41-60Yrs)
2.985200E-01
Normal-vs-Age(61-80Yrs)
2.191000E-01
Normal-vs-Age(81-100Yrs)
1.351950E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.681400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.424400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.534400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.791400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.503800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.078000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.369990E-01
Normal-vs-Daily Drinker
5.865800E-01
Normal-vs-Weekly Drinker
1.998170E-01
Normal-vs-Occasional Drinker
5.525200E-01
Normal-vs-Social Drinker
6.411600E-01
Non Drinker-vs-Daily Drinker
3.591400E-01
Non Drinker-vs-Weekly Drinker
5.941000E-01
Non Drinker-vs-Occasional Drinker
5.547600E-01
Non Drinker-vs-Social Drinker
3.065400E-01
Daily Drinker-vs-Weekly Drinker
6.296800E-01
Daily Drinker-vs-Occasional Drinker
8.592200E-01
Daily Drinker-vs-Social Drinker
8.619400E-01
Weekly Drinker-vs-Occasional Drinker
8.226200E-01
Weekly Drinker-vs-Social Drinker
5.245600E-01
Occasional Drinker-vs-Social Drinker
7.458800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.292800E-01
Normal-vs-Grade 2
8.159800E-01
Normal-vs-Grade 3
5.646600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.400100E-02
Grade 1-vs-Grade 3
8.021900E-02
Grade 1-vs-Grade 4
4.292800E-01
Grade 2-vs-Grade 3
8.526800E-01
Grade 2-vs-Grade 4
8.159800E-01
Grade 3-vs-Grade 4
5.646600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.985700E-02
Normal-vs-NonDiabetic
4.146200E-01
Diabetic-vs-NonDiabetic
1.167180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.110600E-01
Normal-vs-NoPancreatitis
2.780800E-01
Pancreatitis-vs-NoPancreatitis
7.984200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.591000E-01
Normal-vs-N1
1.804220E-01
N0-vs-N1
2.781400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.609600E-02
Normal-vs-TP53-NonMutant
8.506400E-01
TP53-Mutant-vs-TP53-NonMutant
1.036550E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
